Viewing Study NCT04805333


Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2026-05-01 @ 2:16 AM
Study NCT ID: NCT04805333
Status: COMPLETED
Last Update Posted: 2025-02-10
First Post: 2021-03-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Dose Escalation of ArtemiCoffee
Sponsor: Frederick R. Ueland, M.D.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None dose escalation View
None ArtemiCoffee View
None Artemisia annua View
None ART-Coffee View
None herbal View